Scale-up and scale-out of extracellular vesicle production utilizing industrial grade bioreactors

J Ene, F Syed, J Guan et al

23 September 2025

Viewpoint

Bridging preclinical to commercial manufacturing in cell therapy: mind the gap

Ashwin Srinivasan Kumar, Sabry Hamza, Jaichandran Sivalingam

18 September 2025

Viewpoint

Time for the FDA and industry–academia partnerships to invest in fully automated, quality-controlled, scale-out of autologous cell and gene therapies

Krishnendu Roy

17 September 2025

Viewpoint

How AI and precision medicine could transform women’s health

Helena Strigard

08 September 2025

Viewpoint

Avoiding slowdowns on the cell and gene therapy development pathway

William E Janssen, Scott R Burger

02 September 2025

Viewpoint

The AAV CDMO market in August 2025: navigating the crossroads of capacity, complexity, and cost

Rahul Kaushik

02 September 2025

Viewpoint

Genome editing: decoding the technical challenges and balancing precision, safety, and global regulations

Houria Bachtarzi

26 August 2025

Viewpoint

Reference standards for autologous products: material is not immaterial

Alison Caldwell

09 July 2025

Viewpoint

Cryopreservation of autologous patient material for onwards manufacture

Chris Leonforte

02 June 2025

Viewpoint

A path toward universal agreement on fulfilling the need for rapid and reliable sterility assays in gene therapy

Qin Xiang

14 April 2025

Viewpoint

Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason

21 February 2025

Viewpoint

Advancing mRNA-based cell therapies: the crucial role of mRNA optimization for therapeutic efficacy

Christian Bär, Ulrich Blache, Sandy Tretbar

23 January 2025

Viewpoint

Efficient non-viral engineering of immune cells for cell therapy using circular single-stranded DNA

Hao Wu

13 January 2025

Viewpoint

Bio-printing in the context of end-to-end scalable tissue-engineered ATMP manufacturing

Isaak Decoene, Ioannis Papantoniou

12 December 2024

Viewpoint

Industrializing cell therapy: how to bring curative therapies to all patients who need them?

Jens Vogel

20 November 2024

Viewpoint

Overcoming the senescence barrier in stem cell expansion

William Ying Khee Hwang

14 November 2024

Viewpoint

Gene delivery: persistent challenges call for a reference measure

Max Ryadnov

22 October 2024

Viewpoint

Decentralizing gene and cell therapy manufacturing: changing tides or uphill battle

Magdi Elsallab

04 October 2024

Viewpoint

Pioneering the future of non-viral genome engineering

Hao Wu

18 September 2024

Viewpoint

Cellular immunotherapy—a matter of delivery?

Nina Bauer

05 September 2024

Viewpoint

A pathway forward for CAR-NK cell therapy

Scott McComb

06 August 2024

Viewpoint